Pulmonx Corporation
LUNG
$1.58
-$0.01-0.63%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 14.80% | 19.54% | 23.28% | 15.39% | 20.87% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 14.80% | 19.54% | 23.28% | 15.39% | 20.87% |
Cost of Revenue | 21.53% | 29.73% | 26.59% | 15.56% | 22.78% |
Gross Profit | 12.39% | 16.08% | 22.15% | 15.33% | 20.21% |
SG&A Expenses | 5.48% | 7.15% | 10.58% | 5.95% | 7.89% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 6.20% | 11.11% | 12.00% | 5.09% | 8.24% |
Operating Income | 5.24% | -0.19% | 3.61% | 6.90% | 4.97% |
Income Before Tax | 1.61% | -5.53% | 3.69% | 5.99% | 5.06% |
Income Tax Expenses | 110.71% | -27.42% | -84.68% | 225.42% | -40.00% |
Earnings from Continuing Operations | 1.00% | -5.08% | 5.13% | 5.07% | 5.37% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 1.00% | -5.08% | 5.13% | 5.07% | 5.37% |
EBIT | 5.24% | -0.19% | 3.61% | 6.90% | 4.97% |
EBITDA | 4.71% | -1.22% | 3.73% | 6.99% | 5.04% |
EPS Basic | 4.63% | -1.60% | 8.01% | 7.88% | 8.10% |
Normalized Basic EPS | 5.23% | -2.05% | 6.62% | 8.75% | 7.80% |
EPS Diluted | 4.63% | -1.60% | 8.01% | 7.88% | 8.10% |
Normalized Diluted EPS | 5.23% | -2.05% | 6.62% | 8.75% | 7.80% |
Average Basic Shares Outstanding | 3.82% | 3.41% | 3.14% | 3.03% | 2.97% |
Average Diluted Shares Outstanding | 3.82% | 3.41% | 3.14% | 3.03% | 2.97% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |